Vitrolife AB (OSTO:VITR) Change In Receivables : kr-138 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Change In Receivables?

Vitrolife AB's change in receivables for the quarter that ended in Mar. 2025 was kr-26 Mil. It means Vitrolife AB's Accounts Receivable increased by kr26 Mil from Dec. 2024 to Mar. 2025 .

Vitrolife AB's change in receivables for the fiscal year that ended in Dec. 2024 was kr-174 Mil. It means Vitrolife AB's Accounts Receivable increased by kr174 Mil from Dec. 2023 to Dec. 2024 .

Vitrolife AB's Accounts Receivable for the quarter that ended in Mar. 2025 was kr634 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Vitrolife AB's Days Sales Outstanding for the three months ended in Mar. 2025 was 68.71.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Vitrolife AB's liquidation value for the three months ended in Mar. 2025 was kr-1,769 Mil.

Vitrolife AB Change In Receivables Historical Data

The historical data trend for Vitrolife AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Change In Receivables Chart

Vitrolife AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

14.86

-5.00

-56.00

-95.00

-174.00

Vitrolife AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-62.00	-81.00	-21.00	-10.00	-26.00

Vitrolife AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-138 Mil.

Vitrolife AB (OSTO:VITR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Vitrolife AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	634	/	842	*	91
=	68.71

2. In Ben Graham's calculation of liquidation value, Vitrolife AB's accounts receivable are only considered to be worth 75% of book value:

Vitrolife AB's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1054	-	3505	+	0.75 * 634	+	0.5 * 413
=	-1,769

Vitrolife AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

VITRs:UK 0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines